MRNA Latest Headlines

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

at www.tipranks.com (Sat, 6-Jun 9:40 PM)

Moderna’s CMV Vaccine Study Update: What mRNA-1647 Progress Means for MRNA Investors

at www.tipranks.com (Thu, 4-Jun 12:31 PM)

Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian

at seekingalpha.com (Thu, 4-Jun 11:22 AM)

Barclays Sticks to Their Hold Rating for Moderna (MRNA)

at www.tipranks.com (Wed, 3-Jun 4:19 AM)

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Mediwound (MDWD)

at www.tipranks.com (Tue, 2-Jun 11:20 AM)

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Moderna (MRNA) and Celcuity (CELC)

at www.tipranks.com (Tue, 2-Jun 10:50 AM)

Analysts Conflicted on These Healthcare Names: BeOne Medicines (ONC), Moderna (MRNA) and Danaher (DHR)

at www.tipranks.com (Tue, 2-Jun 9:00 AM)

mRNA Cancer Immunotherapy Shows Early Promise as Platform Approaches Gain Traction in Biotech

Market Chameleon (Mon, 11-May 11:49 AM)

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Study—Regulatory Filings Underway Across Four Continents

Market Chameleon (Thu, 7-May 7:13 AM)

Moderna’s Revenue Surges on International Strength and New Vaccine Approvals as Cost Discipline Deepens

Market Chameleon (Fri, 1-May 7:07 AM)

MRNA Fast Track: mRNA-4359 & Pembrolizumab Show 83% Response Rate in First-Line Melanoma Study

Market Chameleon (Mon, 20-Apr 8:13 AM)

Moderna Highlights Encouraging Revaccination Data for Influenza and RSV Vaccines Ahead of Major Regulatory Decisions

Market Chameleon (Tue, 7-Apr 8:32 AM)